Clinical Trials Directory

Trials / Completed

CompletedNCT03292120

Venous to Arterial Carbon Dioxide Difference (P₍ᵥ-ₐ₎CO₂): Predictor of Septic Patient Prognosis Depending on the ScvO₂

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
124 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

the investigators will include 120 patients with a diagnosis of septic shock in accordance with the definition given by the 2001 expert consensus. Two groups of patients are likely to participate in this study: Patient hospitalized in intensive care for a septic shock = Primary patient + patient who develops, the waning of his hospitalization in intensive care for another reason, a septic shock = Secondary patient. Haemodynamic monitoring by transpulmonary thermodilution allow a patient's close monitoring during the initial phase supported. The clinical and biological data, demographic and the severity scores are collected for each patient during the first three days of stay. To predict the unfavorable evolution of the patients, a measure of the SOFA score at the input (J0) and third day (J2) is performed. the investigators analyzed mortality at day 28 in patients with increased P₍ᵥ-ₐ₎CO₂ and those with increasing of organ failure. This research will be conducted according to good clinical practice. An information will be distributed to patients.

Conditions

Interventions

TypeNameDescription
OTHERmeasure of the SOFA scoreThe Sequential Organ Failure Assessment (SOFA) Score predicts ICU mortality based on lab results and clinical data.

Timeline

Start date
2016-06-01
Primary completion
2018-11-01
Completion
2019-05-01
First posted
2017-09-25
Last updated
2019-05-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03292120. Inclusion in this directory is not an endorsement.